R
Rapt Therapeutics (RAPT)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Rapt Therapeutics (RAPT)
RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It... Read more
- USD7.99
- USD8.15
- USD7.85
- USD27.35
- -5.10%
- --
- 709.87k
- 863.16k
- 320M
- 6.86
- -55.80%
Stock News
3 hours ago
Google is combining its Android software and Pixel hardware divisions to more broadly integrate AI
Yahoo
4 hours ago
American Express’s Profits Expected to Rise as Investors Monitor Signs of Slowdown
Yahoo
4 hours ago
Intuitive Surgical (ISRG) Q1 2024 Earnings Call Transcript
Yahoo
4 hours ago
MSCI Inc.: Here's Why I Bought This Stock With Double-Digit Dividend Growth Potential
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
